Publication Name	World Journal of Gastroenterology
Manuscript ID	90593
Country	Greece

Received	2023-12-07 20:27
Peer-Review Started	2023-12-07 20:27
To Make the First Decision
Return for Revision	2023-12-21 20:29
Revised	2024-01-02 22:17
Second Decision	2024-01-30 02:40
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-30 06:18
Articles in Press	2024-01-30 06:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-20 01:15
Publish the Manuscript Online	2024-02-26 13:28

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Management of autoimmune hepatitis induced by hepatitis delta virus
Manuscript Source	Invited Manuscript
All Author List	Eleni Gigi, Vasileios Lagopoulos and Aris Liakos
ORCID	Author(s) ORCID Number Eleni Gigi http://orcid.org/0000-0003-0021-348X Vasileios Lagopoulos http://orcid.org/0000-0002-2366-3283 Aris Liakos http://orcid.org/0000-0003-3261-2979
Funding Agency and Grant Number
Corresponding Author	Eleni Gigi, MD, PhD, Academic Research, Assistant Professor, Hepatology Unit, The Second Internal Medicine Department, Aristotle University Medical School, Hippokrateio General Hospital, 49 Konstantinoupoleos, Thessaloniki 54642, Greece. elengigi@auth.gr
Key Words	Autoimmune hepatitis; Hepatitis delta virus; Bulevirtide; Prednisolone
Core Tip	There are some pressing issues that should be elucidated in order to clarify whether new antiviral treatments for hepatitis delta virus (HDV), such as Bulevirtide, or immunosuppressive drugs, are more appropriate for the management of patients with HDV and autoimmune hepatitis (AIH). Firstly, several questions remain unanswered with the challenge to distinguish whether it is autoimmune or “autoimmune-like” hepatitis being the most crucial. Secondly, it yet remains uncertain whether autoimmunity is induced by the hepatitis B virus or the Delta virus. Finally, if the cause of AIH lies on the previous treatment of HDV with pegylated interferon.
Publish Date	2024-02-26 13:28
Citation	Gigi E, Lagopoulos V, Liakos A. Management of autoimmune hepatitis induced by hepatitis delta virus. World J Gastroenterol 2024; 30(8): 799-805
URL	https://www.wjgnet.com/1007-9327/full/v30/i8/799.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i8.799

Full Article (PDF)	WJG-30-799-with-cover.pdf
Full Article (Word)	WJG-30-799.docx
Manuscript File	90593_Auto_Edited-YJP.docx
Answering Reviewers	90593-Answering reviewers.pdf
Audio Core Tip	90593-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	90593-Conflict-of-interest statement.pdf
Copyright License Agreement	90593-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90593-Language certificate.pdf
Peer-review Report	90593-Peer-review(s).pdf
Scientific Misconduct Check	90593-Bing-Chen YL-2.png
Scientific Editor Work List	90593-Scientific editor work list.pdf